Dr. Mengmeng Wang
的有关信息介绍如下:MengmengWang(M.D.andAssociateProf.)Dr.MengmengWangisaninternationalophthalmologist,whosespecialtyisrefractiveandcataractsurgery.Heisproficientatsmallincisionlenticuleextraction(SMILE),TransPRK,ImplantableCollamerLens(ICL),wavefront-guidedlasik,cross-linking(CXL),andmultifocalIOLimplantation.Hecompletesover1000operationsperyearformyopia,astigmatism,cataract,andkeratoconuspatients.NowDr.WangisworkinginHebeiProvincialEyeHospital,China.Dr.WangisthedeanofInternationalandAcademicAffairsOfficeanddirectorofRefractiveSurgeryDepartmentinthishospital.HebeiProvincialEyeHospital,formerlynamedXingtaiEyeHospital,isoneoftheoldestandlargestophthalmichospitalsinChina.Thishospital,whichgerminatedin1886andwasfoundedin1904,hasbeendevelopedtoapublicandspecialized“TertiaryClass-AHospitalwiththelargestandgrandestophthalmicbuilding(with800openbedsandover1000staffs)inChina.HospitalWebsite:http://www.eyehospital.com/Dr.MengmengWangistheassociateprofessorofHebeiMedicalUniversity.HeisaChineseauthorwiththeover20SCI/SCIE/CSCD/GCJCpublicationsininternationalandChinesescientificjournals.MengmengWang,EffectofGlyceraldehydeCross-LinkingonaRabbitBullousKeratopathyModel,JournalofOphthalmology,vol.2015,ArticleID171690,5pages,2015.doi:10.1155/2015/171690.WangM,CorpuzCC.Effectsofscleralcross-linkingusinggenipinontheprocessofform-deprivationmyopiaintheguineapig:arandomizedcontrolledexperimentalstudy.BMCOphthalmol.2015;
15:89.{Theelectronicversionofthisarticleisthecompleteoneandcanbefoundonlineat:http://www.biomedcentral.com/1471-2415/15/89}ZhangM,ZouY,ZhangF,ZhangX,WangM.EfficacyofBlue-LightCross-linkingonHumanScleralReinforcement.OptomVisSci.2015Aug;
92(8):873-8WangM,CorpuzCC,FujiwaraM,TomitaM.Visualandopticalperformancesofmultifocalintraocularlenseswiththreedifferentnearadditions:6-monthfollow-up.OpenOphthalmolJ.2015;
30(9):1-7.MengmengWang,FengjuZhang,XuZhao,YanzhengSong,MiaoZhang.RiboflavinConcentrationAnalysisinRabbitCorneasBeforeandAfterCornealCollagenCross-LinkingUsingConfocalLaserScanningMicroscopy.Asia-PacificJournalofOphthalmology.2014;
3(6):388-394.MWang,FZhang,KLiu,XuZhao.SafetyEvaluationofRabbitEyesonScleralCollagenCrosslinkingbyRiboflavinandUltravioletA(UVA).ClinExperimentOphthalmol.2015;
43(2):156-163.WangM,CorpuzCC,FujiwaraM,TomitaM.Visualandopticalperformanceofdiffractivemultifocalintraocularlenseswithdifferenthapticdesigns:6monthfollow-up.ClinOphthalmol.2014May14;
8:919-926.许艳,赵旭,张丰菊,王萌萌,郭宁,郑燕,柳静,张秋露.0.1%溴芬酸钠水合物滴眼液在准分子激光原位角膜磨镶术后的临床疗效观察.中华眼科杂志.2013;49(4):320-326.赵旭,王萌萌,张丰菊.紫外线A-核黄素交联加固角巩膜安全性的研究进展.中华眼科杂志.2013;
49(2):189-192.李蓉,许艳,张丰菊,王萌萌.准分子激光原位角膜磨镶术术后早期应用卡替洛尔滴眼液对屈光状态的影响.眼科,2013,22(1):49-52.WangM,ZhangF,QianX,ZhaoX.RegionalBiomechanicalpropertiesofhumanscleraaftercross-linkingbyriboflavin/ultravioletA.JRefractSurg.2012;
28(10):723-728.ZhangF,DengS,GuoN,WangM,SunX.ConfocalComparisonofCornealNerveRegenerationandKeratocyteReactionbetweenFS-LASIK,OUP-SBK,andConventionalLASIK.InvestOphthalmolVisSci.2012;15;
53(9):5536-5544.DengS,WangM,ZhangF,SunX,HouW,GuoN.Cornealsubbasalnervefiberregenerationinmyopicpatientsafterlaserinsitukeratomileusis.NeuralRegenRes.2012Jul15;7(20):1556-1562.王萌萌,宋秀君,苏琪,殷英霞.外源性雌二醇对去势雌性Wistar大鼠晶状体上皮细胞雌激素受体表达的影响.中华实验眼科杂志,2012,30(6):505-509.L.ALevin,D.MAlbert(著);
张丰菊,宋旭东(译).国外经典医学名著译丛:眼科疾病的发病机制与治疗(OcularDiseaseMechanismsandManagement).北京大学医学出版社,2012.(作为译者参与翻译,共译15章)FengjuZhang,ZhengZhou,FangleiYu,ZhiliLu,TingLi,MengmengWang.Comparisonofage-relatedchangesbetweencornealandocularaberrationinyoungandmid-agemyopicpatients.IntJOphthalmol,2011,4(3):286-292.王萌萌,张丰菊.胶原交联在眼科的应用进展.中国实用眼科杂志,2011,29(10):997-1000.王萌萌,宋秀君,殷英霞.雌激素对晶状体保护作用的研究进展.眼视光学杂志,2009,11(5):298-400.Dr.MengmengWangistheassociateSectionEditorofBMCOPHTHALMOLOGYinCataractandRefractiveSurgery.Dr.MengmengWangpresentshisinnovativetechniquesinseveralinternationalvisionscienceandophthalmologymeetings.